Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA)

filings reported holding VRNA - Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share as of Q3 2024.
Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 67.7M shares of 87.4M outstanding shares and own 77.42% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (6.32M shares), NEA Management Company, LLC (5.58M shares), RA CAPITAL MANAGEMENT, L.P. (5.01M shares), MAVERICK CAPITAL LTD (4.22M shares), Vivo Capital, LLC (3.55M shares), Frazier Life Sciences Management, L.P. (3.38M shares), Deep Track Capital, LP (3.18M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.43M shares), FEDERATED HERMES, INC. (2.17M shares), and WELLINGTON MANAGEMENT GROUP LLP (1.88M shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.